Skip to content

Aerobic exercise for cognitive impairment in schizophrenia: a pilot randomized controlled trial

Aerobic exercise for cognitive impairment in schizophrenia: a pilot randomized controlled trial - Aerobic exercise for cognitive impairment in schizophrenia: a pilot randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034910
Enrollment
30
Registered
2018-11-17
Start date
2018-11-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Exercise dosage was a 12-week, 2 sessions/week including 1 individual session (60-minute duration) and 1 group session (60-minute duration). The intensity of each session during the exercise sessions

Sponsors

Medical Corporation Seitaikai Mental Support Soyokaze Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: aged 20-65 years; inpatients in a psychiatric hospital; diagnosis of schizophrenia or schizoaffective disorder based on DSM-5

Exclusion criteria

Exclusion criteria: diagnosis of mental retardation or alcohol or drug disorders (abuse or dependence); any current or history of neurological disorders including head injury, cerebral vascular disorders, epilepsy, or dementia; and the difficulty for implementing aerobic exercise due to physical dysfunction

Design outcomes

Primary

MeasureTime frame
Brief Assessment of Cognition in Schizophrenia (BACS)

Secondary

MeasureTime frame
Schizophrenia Cognition Rating Scale (SCoRS) Quality of Life Scale (QLS) Life Assessment Scale for Mentally Ill (LASMI) Global Assessment of Functioning (GAF) Positive and Negative Syndrome Scale (PANSS) Scale for the Assessment of Negative Symptoms (SANS)

Countries

Japan

Contacts

Public ContactTakeshi Shimada

Medical Corporation Seitaikai Mental Support Soyokaze Hospital Department of Rehabilitation

ot@seitaikai.or.jp0268-35-0305

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026